Bethany Kersse

Analyst, Europe

Bethany joined CG Results in 2021 as an Analyst in the Healthcare team. Prior to CG Results, she worked in competitive intelligence within the pharmaceutical industry, delivering analysis on drug development and monitoring clinical trials. She started her career in healthcare manufacturing, having previously worked in supply chain at Reckitt Benckiser (now Reckitts) in its Consumer Healthcare arm.

Bethany graduated with a BSc in Biomedical Sciences from the University of Manchester and has an MSc in Operations, Project and Supply Chain Management (with pharmaceutical focus) from Alliance Manchester Business School.

Outside of work, Bethany loves to ski; is a self-professed gym class enthusiast; and has a newfound passion for cycling around London, rather than taking the tube. She is also a proud Enactus UK alumni, having previously run several social enterprises during her time at university, so now lends her experience to current Enactus students across the UK.

If you don't like something, change it. If you can't change it, change your attitude – Maya Angelou

Latest Insights

27th September 2022

Pharma Commercialisation Services Update – September 2022

Welcome to our latest update on the outsourced Pharma Commercialisation Services sector.  As well as our usual update on M&A activity, this report takes a deep dive into one of the biggest challenges businesses are currently facing – the War for Talent. A phrase first coined by McKinsey in the late ’90s but one that […]

23rd February 2022

CRO Sector – M&A drivers and market trends – Q1 2022

Whilst the pandemic has caused unprecedented disruption on research and clinical trials, it has also launched the clinical trial landscape into a new area, one with the enhanced utilisation of decentralised trials and the long-awaited embracement of digital technologies to deliver improved patient care, reduced clinical trial costs and speedier outcomes. We have also seen […]

1st February 2022

Pharma Commercialisation Services Update – February 2022

We are pleased to introduce you to the first of our regular sector updates on the outsourced pharma commercialisation sector.  For some time, CG Results Healthcare has been producing sector updates and whitepapers on the two other major areas pharmaceutical companies choose to outsource: manufacturing and research. This report focuses on commercialisation, encompassing Healthcare Marketing, […]

10th November 2021

CDMO Market Update

We are pleased to share with you the CDMO Market Update – November 2021, where we analyse global M&A activity and public market valuations in the CDMO sector. H1 2021 was an exceptional start to the year with 48 deals in total in the CDMO sector, almost reaching the total annual transactions in the previous four […]